US FDA OKs monthly maintenance dosing for Eisai/Biogen’s Alzheimer’s drug
(Reuters) – The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan’s Eisai and partner Biogen (NASDAQ:BIIB)’s Alzheimer’s drug Leqembi, the companies said on Monday. The drug received standard U.S. approval in 2023 after showing it slowed cognitive
Diversified Energy near $1.3 bln deal for Maverick Natural Resources- WSJ
Investing.com– Natural gas firm Diversified Energy Company PLC (NYSE:DEC) is in advanced talks to buy Maverick Natural Resources- a private equity owned firm with operations in the Permian Basin, the Wall Street Journal reported on Sunday. The deal values Maverick at
South Korea reports initial findings of Jeju Air crash to ICAO, U.S. and Thailand
By Jack Kim SEOUL (Reuters) – South Korea’s authorities investigating last month’s Jeju Air plane crash have submitted a preliminary accident report to the U.N. aviation agency and to the authorities of the United States, France and Thailand, an official said
Perplexity AI revises Tiktok merger proposal that could give US government 50% stake, CNBC reports
(Reuters) – Perplexity AI revised the merger proposal it had submitted to TikTok parent ByteDance, CNBC reported on Sunday. The proposal, to create a new entity combining Perplexity and TikTok U.S., would now also allow for the U.S. government to own
Dividend surge signals culture shift in China’s markets
By Jiaxing Li and Ankur Banerjee HONG KONG/SINGAPORE (Reuters) -New shades of capitalism are emerging in China’s tuckered out stock market as companies, at Beijing’s behest, buy back their shares and pay record dividends to investors lying in wait for a